
Jonathan Webster
@leukdocwebster
Assistant Professor of Oncology, Division of Hematologic Malignancies, Leukemia Group, Johns Hopkins University
ID: 1455559440845848578
02-11-2021 15:36:49
16 Tweet
164 Followers
118 Following

Like my decision to join Twitter, this article has been many years in the making. B Douglas Smith authors.elsevier.com/a/1e2mkX17oiL4a

Clonal Hematopoiesis in Donor May Improve Bone Marrow Transplant Outcome. Great work from Lukasz Gondek hopkinsmedicine.org/news/newsroom/…



We are happy to share Andrew Matthews work on: Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia. Thx SelinaLuger @ParalkarLab and UPenn leukemia team doi.org/10.1182/blooda…



Congratulations to Dr. Kristen A. Marrone, MD on receipt of a multi-year career development award from LUNGevity Foundation to study neoadjuvant immunotherapy and targeted therapy for surgical lung cancer harboring a #kras mutation! lungevity.org/news/media-rel…


Embargo lifted! Congratulations to our Johns Hopkins Hematology trainees who were awarded ASH Abstract Achievement Awards!! 🌟Michael Hochman Michael Hochman, Chief Heme Fellow Johns Hopkins Hematology and Oncology Fellowship 🌟Macy Early Macy Early Gatti, ASH Med Student PS Awardee 🌟 Jayla Scott, Hopkins Woodrow Wilson Awardee 🧵

Chris Hourigan presenting words of wisdom from our great mentor Judy Karp at the #ASH22 AML education session.



Great article from Nicholas Short MD and colleagues with important implications for MRD monitoring in Ph+ ALL and our understanding of the fundamental biology underlying Ph+ ALL vs de novo lymphoid blast crisis of CML vs ?Ph+ ALL with CML-like biology.




Congratulations Ashwini Niranjan-Azadi #OslerPride

Congratulations to our fellows (Saumya Maru M.D., Ph.D., Neha Verma, Mari Nakazawa, Nazila Shafagati, Daniel Shu, Michael Conroy, Jesse Handler) on their Conquer Cancer, the ASCO Foundation #ASCOYIA awards and former fellow and current Johns Hopkins Kimmel Cancer Center Asst. Prof. Eric Christenson for the #ASCOCDA!
